Unravelling Eribulin's role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings.
Kapoor A, Gupta A, Sansar B, Gupta P, Mishra BK, Singh A, Upadhyay A, Kumar A, Tripathi M, Chowdhury Z, Patne S, Dhal I, Singh N, Shukla S, Singh SN, Pujari L, Giridhar P, Kapoor AR, Jain Y, Venkatachalam M, Dey S, Vinayak KR.
Kapoor A, et al. Among authors: singh sn.
Ecancermedicalscience. 2024 Nov 28;18:1804. doi: 10.3332/ecancer.2024.1804. eCollection 2024.
Ecancermedicalscience. 2024.
PMID: 39816379
Free PMC article.